SSE/EFI Working Paper Series in Economics and Finance
No 274:
The Impact of Generic Competition on Brand Name Market Shares: Evidence from Micro Data
Thomas Aronsson ()
, Mats A. Bergman ()
and Niklas Rudholm ()
Abstract: This paper analyses how market shares for brand name drugs
are affected by generic competition. The analysis is based on micro data
for twelve different original drugs, which are all subject to generic
competition. For five of these drugs, we find that the price of the
original relative to the average price of the generic substitutes
significantly affects the market share of the original. In addition, the
introduction of a so called "reference price" system appears to have had a
significant impact on the market shares of five original drugs.
Keywords: Pharmaceutical industry; patent expiration; micro data.; (follow links to similar papers)
JEL-Codes: I11; L65; (follow links to similar papers)
21 pages, October 22, 1998
Before downloading any of the electronic versions below
you should read our statement on
copyright.
Download GhostScript
for viewing Postscript files and the
Acrobat Reader for viewing and printing pdf files.
Full text versions of the paper:
hastef0274.pdf.zip 
(zipped) (125kB)
hastef0274.pdf (213kB)
hastef0274.ps.zip PKZipped PostScript (360kB)
hastef0274.ps PostScript file (2.32MB)
Download Statistics
Questions (including download problems) about the papers in this series should be directed to Björn Thodenius ()
Report other problems with accessing this service to Sune Karlsson ()
or Björn Thodenius ().
Programing by
Design by Joachim Ekebom
